CAPHRA Calls on Malaysia to Adopt Risk-Proportionate Regulation to Avoid a Total Ban on E-Cigarettes

Apr.30.2025
CAPHRA Calls on Malaysia to Adopt Risk-Proportionate Regulation to Avoid a Total Ban on E-Cigarettes
CAPHRA calls on Malaysia to adopt risk-proportionate regulation for e-cigarettes, criticizing WHO for ignoring harm reduction and warning that a ban could lead to a black market and increased health risks.

Key points of focus:

The Asia-Pacific Tobacco Harm Reduction Advocates (CAPHRA) is urging the Malaysian government to reject a complete ban on e-cigarettes and instead advocate for regulatory measures proportional to the risks involved.

 

The organization criticizes the World Health Organization (WHO) for ignoring harm reduction strategies, believing that excessive regulation will lead to the expansion of illegal markets and increased health risks.

 

The state-level bans and restrictions triggered by the Malaysian Act 852 on Public Health Tobacco Control Products in 2024 have become a controversial focal point.

 

CAPHRA emphasizes the need to establish clear product regulations and enforcement mechanisms, rather than implementing a blanket ban, in order to ensure consumer safety and market order.


According to a recent report by Tobaccoreporter, the Asia Pacific Harm Reduction Advocates Alliance (CAPHRA) is urging the Malaysian government to avoid implementing a "counterproductive blanket ban" on e-cigarettes in the current tobacco control legislative process, and instead recommends adopting a "risk-proportionate regulation" strategy.

 

The organization pointed out that the World Health Organization (WHO) consistently disregarding harm reduction strategies in global tobacco control policies is a key factor contributing to preventable tobacco-related deaths.

 

CAPHRA's statement comes as some states in Malaysia are considering tightening control over e-cigarette sales, including implementing local bans and setting stricter limits on nicotine content, in response to the "2024 Public Health Tobacco Control Act" (Act 852). CAPHRA warns that if these measures are not carefully implemented, they could inadvertently fuel the expansion of the black market while suppressing legal channels, leading to greater public health risks.

 

CAPHRA further criticizes the World Health Organization for not recognizing the role of e-cigarettes in helping smokers quit smoking. Data shows that despite illegal tobacco trade accounting for 55.3% of the market in Malaysia by 2023, the WHO predicts the country's smoking rate will increase to 30% by 2025. Meanwhile, Sweden, which has adopted harm reduction policies, has reduced its smoking rate to 5%.

 

CAPHRA and related individuals emphasize that the key to regulating e-cigarettes is not to outright ban them, but to establish a reasonable and enforceable regulatory framework that allows reduced harm products to play a positive role in tobacco control policies while also preventing the expansion of illegal markets and the rise of public health hazards.

 

According to its official website, the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) is a coalition of tobacco harm reduction advocates and their respective organizations in the Asia Pacific region. Its primary mission and goal is to educate, advocate for, and uphold the rights of adult nicotine consumers to access and use reduced harm tobacco products.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Argentina Issues Resolution 549/2026 to Regulate Vapes, Heated Tobacco and Nicotine Pouches
Argentina Issues Resolution 549/2026 to Regulate Vapes, Heated Tobacco and Nicotine Pouches
Argentina’s government has created a comprehensive regulatory framework for nicotine products, including vapes, heated tobacco and nicotine pouches, through Resolution 549/2026 published in the Official Gazette. The new regulation ends the previous prohibitive framework and establishes rules to organize the market by requiring traceability, quality standards and mandatory registration for all manufacturers and retailers operating in the country.
May.06 by 2FIRSTS.ai
 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Technology reported financial results on May 7, 2026, for the third quarter of fiscal 2026, covering the three months ended March 31, 2026. Revenue was $18.7 million, compared with $26.2 million in the third quarter of fiscal 2025 and $20.3 million in the prior quarter. Gross profit was $2.0 million, with gross margin of 10.7%. Net loss was $9.5 million, or $0.17 per share. The company said it held $18.0 million in cash as of March 31, 2026, up $468,000 sequentially.
May.08 by 2FIRSTS.ai
China Tobacco International HK Warns First-Half Revenue May Fall 25%-30%, Tobacco Leaf and Duty-Free Exposure Highlight Reliance on Traditional Tobacco
China Tobacco International HK Warns First-Half Revenue May Fall 25%-30%, Tobacco Leaf and Duty-Free Exposure Highlight Reliance on Traditional Tobacco
CTIHK expects first-half 2026 revenue to fall 25%-30%, mainly due to lower tobacco leaf imports and delayed cigarette shipments to China’s domestic duty-free market. Its 2025 revenue mix—nearly 90% from tobacco leaf-related businesses and less than 1% from new tobacco products—shows continued exposure to traditional supply chains and trade variables.
Jun.18
AIR Shares Drop 18.6% in Nasdaq Debut, Testing Hookah’s Move Toward Public Markets
AIR Shares Drop 18.6% in Nasdaq Debut, Testing Hookah’s Move Toward Public Markets
AIR Global’s Nasdaq debut under ticker AIIR ended with a 18.6% first-day decline, giving the global hookah industry a rare public-market reference point. Beyond one company’s share move, the listing raises a broader question: can a culturally rooted, fragmented and venue-based category evolve into a more scalable and investable consumer sector?
Special Report
May.19
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13